Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...
Here are 4 biotech stocks that could get a boost from a more open FDA regulatory climate The key to successful biotech investing is straightforward: Own stocks of companies that get drugs approved.